Maravai Lifesciences Holdings (MRVI) Current Assets (2020 - 2026)

Maravai Lifesciences Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $251.7 million for Q1 2026.

• On a quarterly basis, Current Assets fell 33.1% year-over-year to $251.7 million in Q1 2026; TTM through Mar 2026 was $251.7 million, a 33.1% decrease from a year earlier, with the FY2025 full-year figure at $296.3 million, down 30.97% from the prior year.
• Current Assets eased to $251.7 million in Q1 2026 per MRVI's latest filing, from $296.3 million in the prior quarter.
• Across five years, Current Assets topped out at $847.9 million in Q4 2022 and bottomed at $251.7 million in Q1 2026.
• The 5-year median for Current Assets is $679.1 million (2024), against an average of $587.9 million.
• Across the five-year window, Current Assets jumped 45.49% in 2022 and tumbled 52.02% in 2025, its largest moves.
• Year by year, Current Assets stood at $847.9 million in 2022, then slipped by 17.45% to $699.9 million in 2023, then sank by 38.69% to $429.1 million in 2024, then tumbled by 30.97% to $296.3 million in 2025, then retreated by 15.03% to $251.7 million in 2026.
• Per Business Quant, the three latest MRVI Current Assets figures stand at $251.7 million (Q1 2026), $296.3 million (Q4 2025), and $325.9 million (Q3 2025).